SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $413.00 thousand for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-02-16
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-12-31 was $140.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2019-12-31 was -$144.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2012-12-31 was -$87.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2012-09-30 was $33.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2012 was $251.00K, a 33.07% decline from fiscal 2011.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2011 was $375.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $413.00K 10-Q · filed 2021-02-16 | |||
| 2020-09-30 | $273.00K 10-Q · filed 2020-11-20 | ||||
| 2019-12-31 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $214.00K 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $358.00K 10-Q · filed 2020-11-20 | ||||
| 2012-12-31 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | -$54.00K derived: sum of 2 quarters · filed 2013-02-13 | -$171.00K 10-Q · filed 2013-02-13 | $394.00K derived: sum of 4 quarters · filed 2013-02-13 | |
| 2012-09-30 | $33.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08 | -$84.00K 10-Q · filed 2012-11-08 | $481.00K derived: sum of 3 quarters · filed 2012-11-08 | $423.00K derived: sum of 4 quarters · filed 2013-02-13 | |
| 2012-06-30 | -$117.00K 10-Q/A · filed 2012-08-31 | $448.00K derived: sum of 2 quarters · filed 2012-08-31 | $390.00K derived: sum of 3 quarters · filed 2013-02-13 | $240.00K derived: sum of 4 quarters · filed 2013-02-13 | |
| 2012-03-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $507.00K derived: sum of 2 quarters · filed 2013-02-13 | $357.00K derived: sum of 3 quarters · filed 2013-02-13 | $251.00K 10-K · filed 2012-06-21 | |
| 2011-12-31 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | -$208.00K derived: sum of 2 quarters · filed 2013-02-13 | -$314.00K 10-Q · filed 2013-02-13 | $314.00K 10-Q · filed 2012-02-10 | -$354.00K derived: sum of 4 quarters · filed 2013-02-13 |
| 2011-09-30 | -$150.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08 | -$256.00K 10-Q · filed 2012-11-08 | -$296.00K derived: sum of 3 quarters · filed 2012-11-08 | $327.00K derived: sum of 4 quarters · filed 2012-11-08 | |
| 2011-06-30 | -$106.00K 10-Q/A · filed 2012-08-31 | -$146.00K derived: sum of 2 quarters · filed 2012-08-31 | $477.00K derived: sum of 3 quarters · filed 2012-08-31 | $440.00K derived: sum of 4 quarters · filed 2012-08-31 | |
| 2011-03-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $583.00K derived: sum of 2 quarters · filed 2012-06-21 | $546.00K derived: sum of 3 quarters · filed 2012-06-21 | $375.00K 10-K · filed 2012-06-21 | |
| 2010-12-31 | $623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-10 | $586.00K derived: sum of 2 quarters · filed 2012-02-10 | $415.00K 10-Q · filed 2012-02-10 | ||
| 2010-09-30 | -$37.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-11-03 | -$208.00K 10-Q · filed 2011-11-03 | |||
| 2010-06-30 | -$171.00K 10-Q/A · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |